This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Second View: Checking in with a prescriber of Eli Lilly's Olumiant (baricitinib) for the treatment of COVID-19.

Ticker(s): LLY

Who's the expert?

Institution: Sound Physicians

  • Dual board certified in Internal Medicine and Critical Care Medicine
  • Intensivist working in the ICU with high patient acuity as well as floor consultations
  • Exclusively responsible for decision making regarding the critical care patients and treats roughly 20-30 patients per month with severe COVID

Interview Goal
to discuss the current treatment options and the use of Olumiant (baricitinib) for covid-19.

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.